[1] |
Marples B, Scott SD, Hendry JH, et al. Development of synthetic promoters for radiation-mediated gene therapy[J].Gene Ther, 2000, 7(6):511-517.
|
[2] |
Scott SD, Marples B. Comment on the use of the cre/loxP recombinase system for gene therapy vectors[J]. Gene Ther, 2000, 7(19):1706.
|
[3] |
Kaspar BK, Vissel B, Bengoechea T, et al. Adeno-associated virus effectively mediates conditional gene modification in the brain[J]. Proc Natl Acad Sci USA, 2002, 9(4):2320-2325.
|
[4] |
Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases[J]. Cancer Res, 1999, 59(22):5830-5835.
|
[5] |
Greco O, Marples B, Dachs GU, et al. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation[J].Gene Ther, 2002, 9(20):1403-1411.
|
[6] |
Fillat C, Carrio M, Cascante A, et al. Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene/ganciclovir system:fifteen years of application[J].Curr Gene Ther, 2003, 3(1):13-26.
|
[7] |
Springer C J, Niculescu-Duvaz I. Prodrug-activating systems in suicide gene therapy[J]. J Clin Invest, 2000, 105(9):1161-1167.
|
[8] |
Patterson AV, Saunders MP, Greco O. Prodrugs in genetic chemoradiotherapy[J]. Curr Pharm Des, 2003, 9(26):2131-2154.
|
[9] |
Dilber MS, Phelan A, Aints A, et al. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22[J]. Gene Ther, 1999, 6(1):12-21.
|
[10] |
Rogulski KR, Wing MS, Paielli DL, et al. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytoxicity and radiosensitization[J]. Hum Gene Ther, 2000, 11(1):67-76.
|
[11] |
Cunningham S, Boyd M, Brown MM, et al. A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma[J]. Med Pediatr Oncol, 2000, 35(6):708-711.
|
[12] |
Epperly MW, Gretton JA, DeFillippi SJ, et al. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome(SOD2-PL) gene therapy[J]. Radiat Res, 2001, 155(1):2-14.
|